Indications and strategies of laparoscopic lateral pelvic lymph node dissection for low rectal cancer

doi:10.3877/cma.j.issn.1674-3946.2023.05.003

Abstract

Abstract:

It is controversial to perform mesorectal excision（ME）combined with pelvic lateral lymph node dissection（LPLND）for low rectal cancer，and there are no definite indications for whether to perform prophylactic LPLND as well as therapeutic LPLND after neoadjuvant radiochemotherapy. In addition，intraoperative and postoperative complications of lateral pelvic lymph node dissection should be of concern，especially the occurrence of intraoperative hemorrhage and postoperative genitourinary dysfunction. Therefore，it is important to master the surgical indications for lateral pelvic lymph node dissection in low rectal cancer and to make a surgical strategy to improve the patient's survival and prognosis and to reduce intraoperative and postoperative complications.

Key words: Low Rectal Neoplasms, Total Mesorectal Excision, Laparoscopes, Lateral Pelvic Lymph Node Dissection, Neoadjuvant Chemoradiation

Su Yan. Indications and strategies of laparoscopic lateral pelvic lymph node dissection for low rectal cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(05): 480-484.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhpwkssxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3946.2023.05.003

https://zhpwkssxzz.cma-cmc.com.cn/EN/Y2023/V17/I05/480

Figures/Tables 2

References 24

[1]	Takahashi T，Ueno M，Azekura K，et al. Lateral node dissection and total mesorectal excision for rectal cancer［J］. Dis Colon Rectum，2000，43（Suppl 10）：59-68.
[2]	Hashiguchi Y，Muro K，Saito Y，et al. Japanese Society for Cancer of the Colon and Rectum（JSCCR）guidelines 2019 for the treatment of colorectal cancer［J］. Int J Clin Oncol，2020，25（1）：1-42.
[3]	Sugihara K，Kobayashi H，Kato T，et al. Indication and benefit of pelvic sidewall dissection for rectal cancer［J］. Dis Colon Rectum，2006，49（11）：1663-1672.
[4]	Kapiteijn E，Marijnen CA，Nagtegaal ID，et al. Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer［J］. N Engl J Med，2001，345（9）：638-646.
[5]	Sauer R，Liersch T，Merkel S，et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer：results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years［J］. J Clin Oncol，2012，30（16）：1926-1933.
[6]	Malakorn S，Chang GJ. Treatment of rectal cancer in the East and West：should it be different？［J］. Surgery，2017，162（2）：315-316.
[7]	Songphol M，Yun Y，Brian KB，et al. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation？［J］. Dis Colon Rectum，2019，62（10）：1158-1166.
[8]	Fujita S，Mizusawa J，Kanemisu Y，et al. Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer（JCOG0212）：A Multicenter，Randomized Controlled，Noninferiority Trial［J］. Ann Surg，2017，266（2）：201-207.
[9]	Komori K，Fujita S，Mizusawa J，et al. Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis（clinical stage II/III）：The analysis of data from the clinical trial（JCOG0212）［J］. Eur J Surg Oncol，2019，45（3）：336-340.
[10]	Ohue M，Fujita S，Mizusawa J，et al. Preoperative and postoperative prognostic factors of patients with stage II/III lower rectal cancer without neoadjuvant therapy in the clinical trial（JCOG0212）［J］. Jpn J Clin Oncol，2022，52（2）：114-121.
[11]	Fujita S，Akasu T，Mizusawa J，et al. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer（JCOG0212）：results from a multicentre，randomised controlled，non-inferiority trial［J］. Lancet Oncol，2012，13（6）：616-621.
[12]	Ito M，Kobayashi A，Fujita S，et al. Urinary dysfunction after rectal cancer surgery：Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer（Japan Clinical Oncology Group Study，JCOG0212）［J］. Eur J Surg Oncol，2018，44（4）：463-468.
[13]	Saito S，Fujita S，Mizusawa J，et al. Male sexual dysfunction after rectal cancer surgery：Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer：Japan Clinical Oncology Group Study JCOG0212［J］. Eur J Surg Oncol，2016，42（12）：1851-1858.
[14]	Tsukamoto S，Fujita S，Ota M，et al. Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer（JCOG0212）［J］. Br J Surg，2020，107（5）：586-594.
[15]	Oki E，Shimokawa M，Ando K，et al. Effect of lateral lymph node dissection for mid and low rectal cancer：An ad-hoc analysis of the ACTS-RC（JFMC35-C1）randomized clinical trial［J］. Surgery，2019，165（3）：586-592.
[16]	Heald RJ，Husband EM，Ryall RD. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence？［J］. Br J Surg，1982，69（10）：613-616.
[17]	Akiyoshi T，Matsueda K，Hiratsuka M，et al. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer［J］.Ann Surg Oncol，2015，22 Suppl 3：S614-620.
[18]	Bae JH，Song J，Kim JH，et al. Lateral Lymph Node Size and Tumor Distance From Anal Verge Accurately Predict Positive Lateral Pelvic Lymph Nodes in Rectal Cancer：A Multi-Institutional Retrospective Cohort Study［J］. Dis Colon Rectum，2023，66（6）：785-795.
[19]	Schaap DP，Boogerd LSF，Konishi T，et al. Rectal cancer lateral lymph nodes：multicentre study of the impact of obturator and internal iliac nodes on oncological outcomes［J］. Br J Surg，2021，108（2）：205-213.
[20]	Uyama I，Sugioka A，Matsui H，et al. Laparoscopic lateral node dissection with autonomic nerve preservation for advanced lower rectal cancer［J］. J Am Coll Surg，2001，193（5）：579-584.
[21]	Lim HK，Kim M，Park JW，et al. Laparoscopic versus open lateral pelvic lymph node dissection in locally advanced rectal cancer：multicentre retrospective cohort study［J］. BJS Open，2022，6（3）：zrac068.
[22]	Tang J，Zhou S，Zhao W，et al. Short-and long-term outcomes of laparoscopic versus open selective lateral pelvic lymph node dissection for locally advanced middle-low rectal cancer：Results of a multicentre lateral node study in China［J］. Colorectal Dis，2022，24（11）：1325-1334.
[23]	Yamaguchi T，Konishi T，Kinugasa Y，et al. Laparoscopic Versus Open Lateral Lymph Node Dissection for Locally Advanced Low Rectal Cancer：A Subgroup Analysis of a Large Multicenter Cohort Study in Japan［J］. Dis Colon Rectum，2017，60（9）：954-964.
[24]	Jiang H，Liu H，Li A，et al. Laparoscopic lateral lymph node dissection in two fascial spaces for locally advanced lower rectal cancer［J］. World J Gastroenterol，2021，27（24）：3654-3667.

Please choose a citation manager

Content to export